Strategic Expansion APAC market growth: With a new APAC Business Development Manager (Adam Hamilton) appointed in 2026, there is an opportunity to target regional hospitals and ophthalmic centers for Spectralis software upgrades, OCT angiography enhancements, and multimodal imaging platform deployments.

Product Modernization FDA-cleared Spectralis software upgrade delivering higher OCT angiography scan speeds and advanced eye-tracking creates upsell potential for existing customers and a strong entry point for healthcare providers seeking improved diagnostic workflows and data analytics.

AI driven Recent collaboration with NetraMind Innovations signals openness to AI image analysis; leverage to position RetinAI and automated DICOM workflow solutions to hospitals aiming to reduce reading times and improve accuracy in diagnostics.

Integrated Platform Multimodal Imaging Platform with Ultra High Resolution OCT presented at ARVO 2026 indicates cross-sell opportunities across imaging hardware, image management (PACS), EMR integrations, and data mining capabilities for comprehensive ophthalmic workflows.

Leadership Signals New leadership appointments including a US President and ongoing global account leadership suggest a focus on strategic accounts and larger health systems; target enterprise ophthalmology networks and global accounts for long-term contracts and service expansions.